1. Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial. Issue 7 (July 2019) Authors: West, Howard; McCleod, Michael; Hussein, Maen; Morabito, Alessandro; Rittmeyer, Achim; Conter, Henry J; Kopp, Hans-Georg; Daniel, Davey; McCune, Steven; Mekhail, Tarek; Zer, Alona; Reinmuth, Niels; Sadiq, Ahad; Sandler, Alan; Lin, Wei; Ochi Lohmann, Tania; Archer, Venice; Wang, Lijia; Kowanetz, M... Journal: Lancet oncology Issue: Volume 20:Issue 7(2019) Page Start: 924 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study. Issue 6 (20th February 2023) Authors: Johnson, Melissa L.; Cho, Byoung Chul; Luft, Alexander; Alatorre-Alexander, Jorge; Geater, Sarayut Lucien; Laktionov, Konstantin; Kim, Sang-We; Ursol, Grygorii; Hussein, Maen; Lim, Farah Louise; Yang, Cheng-Ta; Araujo, Luiz Henrique; Saito, Haruhiro; Reinmuth, Niels; Shi, Xiaojin; Poole, Lynne; P... Journal: Journal of clinical oncology Issue: Volume 41:Issue 6(2023) Page Start: 1213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC). (30th September 2019) Authors: Bendell, Johanna C.; Sauri, Tamara; Gracián, Antonio Cubillo; Alvarez, Rafael; López‐López, Carlos; García‐Alfonso, Pilar; Hussein, Maen; Miron, Maria‐Luisa Limon; Cervantes, Andrés; Montagut, Clara; Vivas, Cristina Santos; Bessudo, Alberto; Plezia, Patricia; Moons, Veerle; Andel, Johannes; Benno... Journal: Oncologist Issue: Volume 25:Number 3(2020) Page Start: e451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study. Issue 6 (June 2022) Authors: Cho, Byoung Chul; Abreu, Delvys Rodriguez; Hussein, Maen; Cobo, Manuel; Patel, Anjan J; Secen, Nevena; Lee, Ki Hyeong; Massuti, Bartomeu; Hiret, Sandrine; Yang, James Chih Hsin; Barlesi, Fabrice; Lee, Dae Ho; Ares, Luis Paz; Hsieh, Robert W; Patil, Namrata S; Twomey, Patrick; Yang, Xiaoying; Meng... Journal: Lancet oncology Issue: Volume 23:Issue 6(2022) Page Start: 781 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tumor and host characteristics of small cell lung cancer (SCLC) in U.S. community oncology practice. (4th November 2015) Authors: Richards, Donald; Li, Si G; Anderson, Thomas; Monte, Marc; Ulrich, Brian; Smith, David A; Seetharam, Mahesh; Kaywin, Paul; Page, Ray; Kulig, Kimary; Batenchuk, Cory; Hussein, Maen Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Tumor and host characteristics of small cell lung cancer (SCLC) in U.S. community oncology practice. Issue 2 (December 2015) Authors: Richards, Donald; Li, Si; Anderson, Thomas; Monte, Marc; Ulrich, Brian; Smith, David; Seetharam, Mahesh; Kaywin, Paul; Page, Ray; Kulig, Kimary; Batenchuk, Cory; Hussein, Maen Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗